Labs planning to perform regular surveillance testing should understand that commercial payors and CMS are not necessarily required to cover it. While the recent Feb. 26 Executive Order from President Biden stipulated all COVID-19 tests performed for individual...
Cigna, one of the last remaining payers that reimburses the professional component of clinical pathology, will look to officially end that practice this summer, according to an update posted April 12. In the update to its Modifier 26 Professional Component Policy,...
Multiple labs we work with have recently received pre-payment records requests from UnitedHealthcare to support their Covid-19 testing. While UHC isn’t denying these tests for improper coding, the payments they’ve put on hold amount to nearly $1 million in...
When re-testing Covid-19 specimens to check for variants, Medicare has indicated you may bill U0004 for the second-run of a high-throughput test. For example, if a specimen tests positive, you may run the sample again to check for variants and bill U0004 (or the same...
The following Covid-19 coding changes are effective as of Jan. 1, 2021: REMOVE: Z20.828 should NO LONGER BE USED for possible or suspected exposure to Covid-19 for dates of service (DOS) on or after Jan. 1, 2021. Z11.52 should NO LONGER BE USED for encounter...
A pair of Final Rules issued recently by CMS and the OIG establishes new safe harbors aimed to promote value-based care, while also modifying some of the existing safe harbors. CMS said the intent behind the new rules, which were first proposed in 2019, is to allow...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy